Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

New GM for Bridge Labs' Beijing Facility

publication date: Apr 14, 2009
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Haijun (Lou) Dong, PhD and MBA, was named General Manager of Bridge Laboratory’s Beijing facility. Dr. Dong comes to Bridge from Roche’s R&D operation in Shanghai, where he was part of the senior management team and head of DMPK and Drug Safety at the Shanghai R&D Center for three years. More details...

Stock Symbol: (Switz: ROG)

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...